Results 91 to 100 of about 10,075 (184)

Effect of Inactivated SARS-CoV-2 Vaccines and ChAdOx1 nCoV-19 Vaccination to Prevent COVID-19 in Thai Households (VacPrevent trial)

International Journal of Infectious Diseases, 2022
: Objectives: SARS-CoV-2 is primarily transmitted within households, with massive healthcare system burdens. The role of inactivated vaccines and ChAdOx1 nCoV-19 vaccination in the prevention of within-household transmission remains unknown.
Marisa Muadchimkaew, Taweegrit Siripongboonsitti, Saowanee Wongpatcharawarakul, Chanyapak Boonsankaew, Kriangkrai Tawinprai, Kamonwan Soonklang, Nithi Mahanonda   +6 more
doaj   +1 more source

Classification of Platelet‐Activating Anti‐Platelet Factor 4 Disorders

International Journal of Laboratory Hematology, Volume 48, Issue 2, Page 259-271, April 2026.
ABSTRACT Introduction The prototypic anti‐platelet factor 4 (PF4) disorder—heparin‐induced thrombocytopenia and thrombosis (HITT)—features immunoglobulin G (IgG) class antibodies that activate platelets, monocytes, and neutrophils in a mainly heparin‐dependent fashion via Fcγ receptor‐dependent cellular activation.
Theodore E. Warkentin
wiley   +1 more source

Mass‐Standardised Differential Antibody Binding to a Spectrum of SARS‐CoV‐2 Variant Spike Proteins: Wuhan, Alpha, Beta, Gamma, Delta, Omicron BA.1, BA.4/5, BA.2.75 and BA.2.12.1 Variants—Antibody Immunity Endotypes

Immunology, Volume 177, Issue 4, Page 798-809, April 2026.
Fully quantitative, mass‐standardised, antibody responses to ten SARS‐CoV‐2 variants show significant variation in immunity profiles or endotypes. The incidence of the complete response to all variants is significantly improved after three vaccinations.
Philip H. James‐Pemberton, Shivali Kohli, Jordan Twynham, Aaron C. Westlake, Alex Antill, Rouslan V. Olkhov, Andrew M. Shaw   +6 more
wiley   +1 more source

Vaccine‐induced immune thrombotic thrombocytopenia following AstraZeneca (ChAdOx1 nCOV19) vaccine–A case report

Research and Practice in Thrombosis and Haemostasis, 2021
Vaccination with ChAdOx1 nCov‐19 can result in vaccine‐induced immune thrombotic thrombocytopenia (VITT). This phenomenon mimics heparin‐induced thrombocytopenia (HIT), yet it does not require heparin as a trigger.
Bader Al Rawahi, Hashem BaTaher, Zoheb Jaffer, Aya Al‐Balushi, Asma Al‐Mazrouqi, Noof Al‐Balushi   +5 more
doaj   +1 more source

Sub-optimal neutralisation of omicron (B.1.1.529) variant by antibodies induced by vaccine alone or SARS-CoV-2 Infection plus vaccine (hybrid immunity) post 6-months

EBioMedicine, 2022
Summary: Background: Rapid spread of the omicron SARS-CoV-2 variant despite extensive vaccination suggests immune escape. The neutralising ability of different vaccines alone or with natural SARS-CoV-2 infection against omicron is not well-known ...
Guruprasad R Medigeshi, Gaurav Batra, Deepika Rathna Murugesan, Ramachandran Thiruvengadam, Souvick Chattopadhyay, Bhabatosh Das, Mudita Gosain, Ayushi, Janmejay Singh, Anantharaj Anbalagan, Heena Shaman, Kamal Pargai, Farha Mehdi, Soon Jyoti Das, Namrata Kahlon, Savita Singh, Pallavi Kshetrapal, Nitya Wadhwa, Anil K Pandey, Shinjini Bhatnagar, Pramod Kumar Garg   +20 more
doaj   +1 more source

Sex Differences in Response to Viral Vector Vaccines—Implications for Future Vaccine Design

Immunological Reviews, Volume 338, Issue 1, March 2026.
ABSTRACT Vaccination represents one of the most impactful public health achievements, preventing 3.5 to 5 million deaths annually according to estimates of the World Health Organization. Yet, recent outbreaks of emerging and reemerging infectious diseases highlight the need for rapid and strategic vaccine development using vaccine platforms ...
Ilka Grewe, Tamara Zoran, Marylyn Martina Addo   +2 more
wiley   +1 more source

Effectiveness of COVID‐19 Vaccination in Reducing Severity Among SARS‐CoV‐2 Infected Patients: A Prospective Study From Iraq

Health Science Reports, Volume 9, Issue 2, February 2026.
ABSTRACT Background Coronavirus disease 2019 (COVID‐19) is a lethal global pandemic that originated in Wuhan, China at the end of 2019. As with other viral infectious diseases, the introduction of an effective vaccine is crucial for stopping the spread of the pandemic. In Iraq the COVID‐19 vaccination campaign started on March 2, 2021.
Ahmed Hakim Al‐Obaidi, Marwan Majeed Ibrahim, Abdul Hameed Abdul Majeed Al‐Qaseer   +2 more
wiley   +1 more source

Secondary Immune Thrombocytopenia (ITP) Associated with ChAdOx1 Covid-19 Vaccination – A Case Report

TH Open, 2021
Novel mRNA and vector-based covid-19 vaccinations have shown high efficacy in preventing symptomatic COVID-19 infections. Compared with the number of performed vaccinations, rates of severe side effects seem low.
Martin Koch, Sybille Fuld, Jan M. Middeke, Julia Fantana, Simone von Bonin, Jan Beyer-Westendorf   +5 more
doaj   +1 more source

Cutaneous Lymphomas and Lymphoproliferative Disorders Associated With SARS‐CoV‐2 Vaccination: A Systematic Review

Journal of Skin Cancer, Volume 2026, Issue 1, 2026.
Background Cutaneous lymphomas (CLs) are rare neoplastic skin disorders, primarily of T‐cell origin. Since the widespread rollout of SARS‐CoV‐2 vaccines, several cases of CLs and non‐neoplastic lymphoproliferative disorders (nn‐LPDs) temporally associated with vaccination have been reported, raising concerns about a potential immunologic link ...
Martina Mussi, Corrado Zengarini, Alberto Corrà, Tullio Brunetti, Alessio Natale, Michelangelo La Placa, Bianca Maria Piraccini, Alba Guglielmo, Alessandro Pileri, Richa Sharma   +9 more
wiley   +1 more source

Acute Polyserositis with Cardiac Tamponade and Bilateral Refractory Pleural Effusion after ChAdOx1 nCoV-19 Vaccination

, 2022
The association of SARS-CoV-2 messenger ribonucleic acid vaccines with pericarditis in young adults has been reported. However, data regarding other types of vaccines are extremely limited.
Lee, Chang-Ching, Huang, Chin-Chou, Li, Guan-Yi, Chin-Chou Huang, Guan-Yi Li, Chang-Ching Lee   +5 more
core   +1 more source